Carl Zeiss to acquire Acri.Tec

Article

Carl Zeiss Meditec has announced that it intends to acquire Acri.Tec.

Carl Zeiss Meditec has announced that it intends to acquire Acri.Tec.

Acri.Tec generated sales revenues in the 2006 financial year of €15.4 million. The enterprise value calculated for the company totals €24 million and has to be reduced by the net financial debt at the closing date in order to determine the final purchase price.

Carl Zeiss will acquire all Acri.Tec shares against a cash settlement. The transaction is subject to approval by the German anti-trust authority but, once this approval has been given, the acquisition is expected to be closed during October 2007.

Recent Videos
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.